Background: Linezolid is often the drug of last resort to treat infections caused by Gram-positive cocci. Linezolid resistance can be mutational (23S rRNA or L-protein) or, less commonly, acquired [predominantly cfr, conferring resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A compounds (PhLOPS A ) or optrA, encoding oxazolidinone and phenicol resistance].
Introduction
Linezolid is often the antibiotic of last resort for serious Gram-positive cocci infections. Linezolid resistance is mediated by: (i) mutations in the 23S rRNA gene, altering the drug-binding site, and/or the 50S ribosomal proteins L3, L4 and L22, impairing linezolid binding; or (ii) acquisition of the primarily plasmid-encoded genes cfr, encoding a methyltransferase, or optrA, encoding an ABC transporter, or the cfr homologues cfr(B) and cfr(C). [1] [2] [3] [4] [5] While cfr can mediate the PhLOPS A phenotype (resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A compounds), optrA confers oxazolidinone and phenicol resistance only. 2, 6 Reports of cfr and/or optrA-mediated linezolid resistance among clinical staphylococcal and enterococcal isolates are rare. 7 A Staphylococcus sciuri plasmid harbouring cfr and optrA has been described in addition to two cfr-and optrA-positive Enterococcus faecium isolates, although the co-location of these genes in E. faecium was not shown. 8, 9 We describe a combination of mutational and acquired (cfr) linezolid resistance among linezolid-resistant (LZDR) and V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
methicillin-resistant Staphylococcus epidermidis (MRSE) isolates recovered in 2013/14 during an outbreak investigation in an Irish hospital and the co-location of cfr and optrA on a plasmid in an LZDR vancomycin-resistant Enterococcus faecium (VRE) isolate.
Materials and methods
Thirteen LZDR-MRSE isolates recovered between April 2013 and January 2014 from 12 patients and one environmental site during an ICU outbreak in a large acute care hospital in Dublin, Ireland were investigated (Table 1 ). An LZDR-VRE isolate (F120805) recovered from a patient who subsequently presented with LZDR-MRSE (M13/0451) was also investigated. Isolates were identified to the species level and as methicillin or vancomycin resistant using the VITEK 2 GP ID card and the AST P580 panel (BioMérieux, Marcy l'Étoile, France), respectively. Isolates underwent susceptibility testing with 26 antimicrobial agents and heavy metals by disc diffusion and were investigated for the PhLOPS A phenotype, as described previously. 10, 11 Plasmid curing and conjugation experiments were performed on the cfr-positive MRSE and VRE isolates as described previously. 12 Genomic DNA was extracted using the DNeasy Blood and Tissue Kit (Qiagen, Crawley, West Sussex, UK). Isolates underwent DNA microarray profiling using the Staphylococcus aureus Genotyping Kit 2.0 (Alere Technologies GmbH, Jena, Germany) for the detection of antimicrobial resistance genes, including cfr. 13 The MRSE isolates underwent WGS using a MiSeq desktop sequencer (Illumina, Essex, UK) and WGS libraries were prepared using Nextera XT library preparation reagents (Illumina). The Illumina 500-cycle Reagent Kit v2 was used and small whole-genome sequences, i.e. bacterial genomes, were targeted, generating 2%250 paired end reads, which were checked for quality, trimmed and assembled into contigs using (i) a Velvet de novo assembler (SeqSphere software version 2.3, Ridom GmbH, Germany) for cfr-plasmid analysis, or (ii) a SPAdes de novo assembler (BioNumerics version 7.6; Applied Maths, Saint-Martens-Latem, Belgium) for SNP and SCCmec-element analysis. WGS was performed on the VRE isolate using a Pacific Biosciences (PacBio) RS sequencing system (Menlo Park, CA, USA) with subsequent Hierarchical Genome Assembly Process (HGAP.3) analysis [The Genome Analysis Centre (TGAC), Norwich, UK]. For PacBio WGS, genomic DNA was checked for quality and concentration using TGAC guidelines.
Contigs carrying cfr or mecA were identified using the BioNumerics Genome Analysis Tool (GAT). The most similar BLAST matches (http://blast. ncbi.nlm.nih.gov/Blast.cgi) were identified and BioNumerics chromosomal comparisons were performed to align these to the contigs of the respective strain under investigation, i.e. M13/0451 and F120805 for cfr plasmids and M13/0660 for SCCmec, to identify all cfr-plasmid and SCCmec-element contigs and to predict ORFs. The cfr plasmids in F120805 and M13/0451 and the SCCmec element of M13/0660 were identified on one, two and four contigs, respectively. Contig gaps were closed by PCR. The nucleotide sequence of the cfr plasmid pSEM13-0451 from MRSE isolate M13/0451, the SCCmec III element from MRSE isolate M13/0453 and the cfr-and optrAencoding plasmid pEF12-0805 from VRE isolate F120805 have been deposited in GenBank (accession numbers KY579373, MF062491 and KY579372, respectively).
The seven MLST loci were identified in the VRE and MRSE isolates from the genome assemblies using BioNumerics and the MLST database (http:// www.mlst.net). The remaining eight VRE PacBio contigs (a total of 10 were identified, one cfr-plasmid contig and one chromosomal contig) underwent BLAST analysis to identify additional resistance determinants.
For SNP analysis, the MRSE genomes were resequenced against 81 contigs of the cfr-negative isolate M13/0660. This was deemed to be more appropriate than using a publicly available genome since preliminary SNP analysis revealed a close relationship between the cfr-negative MRSE isolates. The average coverage across all 13 genomes was %120. SNP positions involving an unreliable (N) or ambiguous (non-AGCT) base were removed, as were insertions and deletions and repeat regions. SNP positions required a minimum of %40 coverage and the minimum distance between retained SNPs was 12 bp. Synonymous and non-synonymous mutations were included. BioNumerics was used to perform whole-genome SNP analyses between M13/0660 and every other isolate genome as described previously. 14 For all isolates, the V domain of each 23S rRNA allele was amplified and sequenced to identify specific mutations, as described previously, 15, 16 with the exception of allele 3, which was amplified using novel primers rrlC2F (5 0 -CTCCACCAGGTAATATTAGACC-3 0 ) and rrlC2R (5 0 -GATATATTCGGAACATC TTCTACG-3 0 ). The sequences obtained were compared with the corresponding sequences of the linezolid-susceptible S. epidermidis strain ATCC 12228 (GenBank accession number NC_004461.1) and Enterococcus faecium strain Aus0004 (CP003351.1).
Results and discussion
All 13 LZDR-MRSE isolates exhibited the PhLOPS A phenotype and lacked optrA and cfr(B), and one isolate (M13/0451) harboured cfr ( Table 1 ). The LZDR-VRE isolate (E. faecium) F120805, recovered from the same patient as M13/0451, exhibited the PhLOPS A phenotype, lacked cfr(B) and harboured cfr and optrA (Table 1) . Following MiSeq WGS, exclusion of contigs ,300 bp and GC content analysis, SPAdes de novo assembly of the cfr-positive MRSE isolate M13/0451 genome yielded 98 contigs, a genome size of 2.7 Mb and a novel 8558 bp cfr plasmid (pSEM13-0451) (Figure 1a) . The PacBio WGS of the cfr-positive VRE isolate F120805 yielded 10 contigs, a genome size of 3.4 Mb and a novel 72924 bp cfr-and optrAencoding plasmid (pEF12-0805) (Figure 1b) . The MRSE and VRE cfr plasmids differed in additional antimicrobial resistance gene content [pSEM13-0451: lsa(B) and erm(T); pEF12-0805: lnu(B), lnu(E), erm(A), erm(B), aphA3 and aadE], plasmid mobilization machinery in the region surrounding cfr (pSEM13-0451: pre/mob; pEF12-0805: ISEnfa5) and overall genetic organization [ Figure 1(a and b) and Figure S1 , available as Supplementary data at JAC Online]. The cfr plasmid pSEM13-0451 was most similar to cfr-carrying plasmids pSCFS1 and pSS-03 (96% and 95% DNA sequence identity with 65% and 72% coverage, respectively) ( Figure 1a) . It was more similar in size and genetic content to pSS-03 (7.1 kb), apart from the presence of a truncated low-level lincosamide resistance gene, lsa(B), in pSEM13-0451, with 99% DNA sequence identity (96% coverage) to lsa(B) in pSCFS1 and in cfr plasmid pSAM13-0401 from an Irish MRSA isolate (Figure 1a ). These findings indicate that pSEM13-0451 likely resulted from a pre/mob-driven recombination event between pSS-03-like and pSCFS1-like plasmids, resulting in the integration of a truncated lsa(B) gene into a pSS-03-like backbone.
The 10 kb region surrounding cfr in pEF12-0805 exhibited 99% DNA sequence identity to the cfr-containing plasmid En77, which had a similar genetic organization to the Streptococcus suis cfr plasmid pStrcfr (Figure 1b) . The optrA gene was located 15 kb downstream of cfr in pEF12-0805 and an 6 kb region surrounding optrA exhibited 99% DNA sequence identity to the chromosomelocated optrA region in Enterococcus faecalis strains LY4 and E016 (Figure 1b) . The regions outside of cfr and optrA of pEF12-0805 ( Figure S1 ) exhibited DNA sequence identity to various enterococcal plasmids, most significantly to the Inc18-like family of broadhost-range multiresistance conjugative plasmids, e.g. pRE25 [50 kb aphA3-, sat4-, aadK-, cat-and erm(B)-encoding plasmid, 96% DNA sequence identity and 63% coverage; X92945.2]. The mosaic structure of pEF12-0805 suggests that it emerged cfr plasmid in MRSE and cfr and optrA plasmid in VRE from the integration of cfr-and optrA-containing regions into an Inc18-like plasmid backbone. Plasmid pEF12-0805 was also distinct from the previously described S. sciuri cfr-and optrA-encoding plasmid pWo28-3. 8 While optrA has not been detected in S. aureus, expression of optrA plasmids in S. aureus laboratory strains has been demonstrated. 2 However, several attempts to generate plasmid-cured derivatives of M13/0451 and F120805 and to transfer the cfr-encoding plasmids into the S. aureus laboratory strain XU21 by filter mating were unsuccessful.
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The LZDR-MRSE isolates were assigned to ST2 and harboured a 52 kb SCCmec III element integrated within orfX in the opposite orientation to previously described SCCmec elements, i.e. orfXcopA-asrR-merA/B-ccrAB3-cadC/B-class A mec. The 12 cfr-negative MRSE exhibited 1-52 SNPs but differed from the cfr-positive isolate by 202-223 SNPs (Table S1 ). Although there are no published data for MRSE, multiple S. aureus colonies recovered from a single patient swab vary by up to 40 SNPs 14, 17 Therefore, the maximum SNP difference of 52 detected among the 12 cfr-negative MRSE recovered over 9 months was interpreted as representing closely related isolates while the cfr-positive isolate was deemed to be distinct.
A review of WGS and microarray data for the 12 cfr-negative MRSE failed to identify gene combinations that could confer a PhLOPS A phenotype (Table S2 ). All 12 cfr-negative MRSE and the VRE harboured linezolid resistance-associated mutations in the 23S rRNA gene (G2576T) and 50S ribosomal proteins ( Table 1) . The G2576T mutation can mediate cross-resistance to phenicols, lincosamides, pleuromutilins and streptogramin A compounds due to the proximity of the binding sites. 18, 19 Conceivably, unknown gene(s) may also have contributed to the PhLOPS A phenotype.
All isolates with the G2576T 23S rRNA mutations exhibited a linezolid MIC .256 mg/L, apart from the VRE (8 mg/L). A positive correlation between the number of mutated 23S rRNA alleles and linezolid MIC has been demonstrated and the VRE exhibited the G2576T 23S rRNA mutation in 4/6 alleles compared with 5/6 or 6/6 alleles in 11/12 cfr-negative MRSEs. 19 The one MRSE with 4/6 mutated 23S rRNA alleles also had a linezolid MIC of 256 mg/L but harboured an L3 F147I mutation that has been associated previously with an elevated linezolid MIC. 20 The VRE was assigned to ST80 and analysis of the eight remaining PacBio contigs, outside of the main chromosomal and cfr/optrA-plasmid contigs, revealed that they ranged in size from 1.7 to 287 kb and all exhibited homology to previously described enterococcal plasmids. However, resistance genes were identified on one contig only (287 kb), which harboured the vanA gene cluster (vanA, vanR, vanS, vanH, vanY and vanZ) with 100% DNA sequence identity to previously described vanA gene clusters, e.g. E. faecalis pSL1; CP012468.1. ORFs with DNA sequence similarity (99% and 100%, respectively) to cadmium (cadD) and copper (encoding a copper-translocating P-type ATPase) resistance genes in several E. faecium plasmids, e.g. pE1_230 (CP018066), were identified 27 kb downstream of the vanA gene cluster.
Owing to the variety of linezolid resistance mechanisms identified in these isolates, it is likely that linezolid exposure played a role in their emergence. Nine of the MRSE and the VRE were recovered from patients who had received linezolid prior to isolate recovery ( The cfr-positive MRSE isolate M13/0451 harboured erm(T) on the cfr plasmid ( Figure 1a ) but was phenotypically susceptible to macrolides. A total of 20 bp nucleotide substitutions were identified in erm(T) in M13/0451, including a G-to-A substitution in the start codon.
cfr plasmid in MRSE and cfr and optrA plasmid in VRE JAC Figure 1 . Schematic representation of (a) the cfr-containing regions in ST2-MRSE-III plasmid pSEM13-0451 identified in the present study (surrounded by a blue box) and comparator plasmids pSS-03 (GenBank accession number JQ219851), pSCFS1 (AJ579365) and pSAM13-0401 (KU510528). (b) The cfr and optrA region in ST80-VRE plasmid pEF12-0805 and comparator plasmids En83/En77 (KF792824.1/KF792825.1), pStrcfr (KC844836), LY4 (KT862785.1) and E016 (KT862781.1). Arrows indicate the direction of transcription of each ORF. Each gene or group of genes is represented by different colour shading: red, cfr; green, optrA; orange, antibiotic resistance genes other than cfr and optrA; blue, transposition/mobilization/recombination genes or IS elements; purple, conjugative transfer genes; grey, genes encoding hypothetical proteins or plasmid-specific proteins; yellow, radC.
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In conclusion, WGS revealed the presence of novel and distinct cfr and cfr/optrA plasmids in an MRSE and VRE isolate and identified a cfr-negative LZDR-MRSE ICU outbreak and a distinct cfr-positive LZDR-MRSE from the same ICU. More prudent use of linezolid is vital if further spread of cfr and optrA and emergence of mutational linezolid resistance is to be prevented.
